Pulse Pressure Correlates in Humans with a Proscillaridin A Immunoreactive Comuound

Hypertension

Volumn 27, Issue 5, 1996, Pages 1073-1078

  Sich, Beate ^a   Kirch, Ulrike ^a   Tepel, Martin ^b   Zidek, Walter ^b   Schoner, Wilhelm ^a  

^a JUSTUS LIEBIG UNIVERSITY   (Germany)

^b UNIVERSITY OF MÜNSTER   (Germany)

Author keywords

Blood pressure; Bufanolides; Hypertension, essential; Immunoassay; Na+ K+ exchanging ATPase; Proscillaridin A; Pulse pressure

Indexed keywords

ADENOSINE TRIPHOSPHATASE (POTASSIUM SODIUM); BUFADIENOLIDE; CARDENOLIDE; POLYCLONAL ANTIBODY; PROSCILLARIDIN; RUBIDIUM 86; STEROID HORMONE;

ADULT; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; CROSS REACTION; ENZYME LINKED IMMUNOSORBENT ASSAY; ESSENTIAL HYPERTENSION; FEMALE; HUMAN; HUMAN CELL; IMMUNOREACTIVITY; MALE; PRIORITY JOURNAL; PULSE PRESSURE; REVERSED PHASE HIGH PERFORMANCE LIQUID CHROMATOGRAPHY;

ADULT; ANIMALS; BLOOD PRESSURE; BUFANOLIDES; CHOLENES; CROSS REACTIONS; ENZYME-LINKED IMMUNOSORBENT ASSAY; FEMALE; HUMANS; HYPERTENSION; KIDNEY FAILURE, CHRONIC; MALE; MIDDLE AGED; PROSCILLARIDIN; RABBITS; REFERENCE VALUES; SYSTOLE;

EID: 0029914529     PISSN: 0194911X     EISSN: None     Source Type: Journal    
DOI: 10.1161/01.HYP.27.5.1073     Document Type: Article

References (28)

1. DeWardener HE, Clarkson EM. Concept of natriuretic hormone. Physiol Rev. 1985;65:658-759.
2. Haddy FJ, Buckalew VM Jr. Endogenous digitalis-like factors in hypertension. In: Laragh JH, Brenner BM, eds. Hypertension: Pathophysiology, Diagnosis, and Management. 2nd ed. New York, NY: Raven Press Publishers; 1995:1055-1067.
3. Goto A, Yamada K, Yagi N, Yoshioka M, Sugimoto T. Physiology and pharmacology of endogenous digitalis-like factors. Pharmacol Rev. 1992;44:377-399.
4. Schoner W. Endogenous digitalis-like factors. Prog Drug Res. 1993; 41:249-291.
5. Hamlyn JM. Discovery of endogenous ouabain: a new mammalian hormone. In: Bamberg E, Schoner W, eds. The Sodium Pump Structure, Mechanism, Hormonal Control and its Role in Disease. Darmstadt, FRG: Steinkopff; New York, NY: Springer-Verlag; 1994:722-731.
6. Laredo J, Hamilton BP, Hamlyn JM. Ouabain is secreted by bovine adrenocortical cells. Endocrinology. 1994;135:794-797.
7. Hamlyn JM, Manunta P. Ouabain, digitalis-like factors and hypertension. J Hypertens. 1992;10(suppl 7):S99-S111.
8. Tymiak AA, Norman JA, Bolgar M, DiDonato GC, Lee H, Parker WL, Lo L-C, Berova N, Nakanishi K, Haber E, Haupert GA. Physicochemical characterization of a ouabain isomer isolated from bovine hypothalamus. Proc Natl Acad Sci U S A. 1993;90:8189-8193.
9. Goto A, Ishiguro T, Yamada K, Ishii M, Yoshioka M, Eguchi C, Shimora M, Sugimoto T. Isolation of a urinary digitalis-like factor indistinguishable from digoxin. Biochem Biophys Res Commun. 1990;173:1093-1101.
10. Shaikh IM, Lau BWC, Siegfried BA, Valdes R Jr. Isolation of digoxin-like immunoreactive factors from mammalian adrenal cortex. J Biol Chem. 1991;266:13672-13678.
11. Poston L. Sodium transport inhibitors in pregnancy-induced hypertension. Cardiovasc Drugs Ther. 1990;4:351-356.
12. Lichtstein D, Gati I, Samuelov S, Berson D, Rozenman Y, Landau L, Deutsch J. Identification of digitalis-like compounds in human cataractous lenses. Eur J Biochem. 1993;216:261-268.
13. +-ATPase inhibition during voluntary hypoventilation. Hypertension. 1995;26:781-788.
14. Minta A, Tsien RY. Fluorescent indicators for cylosolic sodium. J Biol Chem. 1989;264:19449-19457.
15. Terano Y, Tomii A, Masugi F. Production and characterization of antibodies to ouabain. Jpn J Med Sci Biol. 1991;44:123-139.
16. Harris DW, Clark MA, Fisher JF, Hamlyn JM, Kolbasa KP, Ludens JH, DuCharme DW. Development of an immunoassay for endogenous digitalislike factor. Hypertension. 1991;17:936-943.
17. 2 conformation of Na,K ATPase molecule. Biochem Biophys Res Commun. 1988;150:648-654.
18. Hamlyn JM, Harris DW, Ludens JH. Digitalis-like activity in human plasma: purification, affinity and mechanism. J Biol Chem. 1989;264:7395-7407.
19. Wenzel M, Heidrich E, Kirch U, Moreth-Wolfrat K, Wizemann V, Schoner W. Increased concentrations of a circulating sodium pump inhibitor in essential hypertension and uremia and its partial purification from hemofiltrate. Physiol Bohemoslovaca. 1990;39:79-85.
20. Dixon WJ. BMDP Statistical Software Manual. Los Angeles, Calif: University of California Press; 1992.
21. Haddy F, Overbeck HW. The role of humoral agents in volume expanded hypertension. Life Sci. 1976;19:935-947.
22. Blaustein MP. Sodium ions, calcium ions, blood pressure regulation, and hypertension: a reassessment and a hypothesis. Am J Physiol. 1977;232:C165-C173.
23. Hamlyn JM, Manunta P, Hamilton BP. Endogenous ouabain in the pathogenesis of hypertensive and cardiovascular disorders. In: Laragh JH, Brenner BM, eds. Hypertension: Pathophysiology, Diagnosis, and Management. 2nd ed. New York, NY: Raven Press Publishers; 1995:1069-1081.
24. Balzan S, Ghione S, Bives P, Gazetti P, Montali U. Partial purification of endogenous digitalis-like compound(s) in cord blood. Clin Chem. 1991;37:277-281.
25. Eliades D, Swindall B, Johnston J, Pamnani M, Haddy F. Hemodynamic effects of bufalin in the anesthetized dog. Hypertension. 1989;13:690-695.
26. Pamnani MB, Chen S, Yuan CM, Haddy FJ. Chronic blood pressure effects of bufalin, a sodium-potassium ATPase inhibitor, in rats. Hypertension. 1994;23(suppl I):I-106-I-109.
27. Sich B, Kirch U, Antolovic R, Schoner W. Demonstration of inhibitors of the sodium pump in human plasma and bovine adrenals crossreacting with proscillaridin A antibodies. In: Bamberg E, Schoner W, eds. The Sodium Pump Structure, Mechanism, Hormonal Control and its Role in Disease. Darmstadt, FRG: Steinkopff; New York, NY: Springer-Verlag; 1994:767-770.
28. Sweadner KJ. Multiple digitalis receptors: a molecular perspective. Trends Cardiovasc Med. 1993;3:2-6.